A
Arief Wibowo
Researcher at Padjadjaran University
Publications - 21
Citations - 634
Arief Wibowo is an academic researcher from Padjadjaran University. The author has contributed to research in topics: Meta-analysis & Odds ratio. The author has an hindex of 8, co-authored 21 publications receiving 220 citations. Previous affiliations of Arief Wibowo include Katholieke Universiteit Leuven.
Papers
More filters
Journal ArticleDOI
Cardiac injury is associated with mortality and critically ill pneumonia in COVID-19: A meta-analysis.
Anwar Santoso,Raymond Pranata,Arief Wibowo,Makhyan Jibril Al-Farabi,Ian Huang,Budhi Antariksa +5 more
TL;DR: Cardiac injury is associated with mortality, need for ICU care, and severity of disease in patients with COVID-19, and this meta-analysis showed that cardiac injury was associated with higher mortality.
Journal ArticleDOI
Prognostic value of elevated lactate dehydrogenase in patients with COVID-19: a systematic review and meta-analysis.
TL;DR: In this article, a meta-analysis aimed to evaluate the prognostic performance of elevated lactate dehydrogenase (LDH) in patients with COVID-19, and the outcome of interest was composite poor outcome, defined as a combined endpoint of mortality, severity, need for invasive mechanical ventilation and need for intensive care unit care.
Journal ArticleDOI
Low Serum 25-hydroxyvitamin D (Vitamin D) Level Is Associated With Susceptibility to COVID-19, Severity, and Mortality: A Systematic Review and Meta-Analysis
TL;DR: In this article, a systematic review and meta-analysis aimed to assess whether low serum 25-hydroxyvitamin D (25-OHD) level is associated with susceptibility to COVID-19, severity, and mortality.
Journal ArticleDOI
Left and right ventricular longitudinal strains are associated with poor outcome in COVID-19: a systematic review and meta-analysis
Arief Wibowo,Raymond Pranata,Raymond Pranata,Astri Astuti,Badai Bhatara Tiksnadi,Erwan Martanto,Januar Wibawa Martha,Augustine Purnomowati,Mohammad Rizki Akbar +8 more
TL;DR: This study shows that lower LV-GLS and RV-LS measurements were associated with poor outcome in patients with COVID-19, and the main outcome was poor outcome, defined as a composite of mortality and severe COIDs.
Journal ArticleDOI
Dipeptidyl peptidase-4 (DPP-4) inhibitor and mortality in coronavirus disease 2019 (COVID-19) - A systematic review, meta-analysis, and meta-regression.
Iis Inayati Rakhmat,Yudith Yunia Kusmala,Dewi Ratih Handayani,Henny Juliastuti,Eka Noneng Nawangsih,Arief Wibowo,Michael Anthonius Lim,Raymond Pranata,Raymond Pranata +8 more
TL;DR: In this paper, the authors synthesize evidence on dipeptidyl peptidase-4 (DPP-4) inhibitor and mortality in COVID-19 patients and factors affecting it.